Study of the Role of Soluble Forms of RAGE (sRAGE/esRAGE) as Diagnostic and Prognostic Biomarkers of Systemic Lupus Erythematosus.

计划入组 150 人 · 首次发布于 2016 年 9 月 7 日

AGE/sRAGE Ratio in Diabetic Periodontitis

计划入组 64 人 · 首次发布于 2024 年 7 月 23 日

Soluble Advanced Glycation End Product (sRAGE) Levels

计划入组 88 人 · 首次发布于 2025 年 1 月 13 日

Keragen Implant

SGN-CEACAM5C(Seagen)

anti-GPC3 ADC(Seagen)

STRAGEN-FRANCE

France

Seagen Inc.

United States

Stragen France SAS.

Seragem's Master V7 Massage Device Receives FDA Approval for Multiple Therapeutic Indications

Former Seagen CEO Leads Ottimo Pharma's Novel Cancer Immunotherapy Development

Hera Biotech Acquires HeraFem Point-of-Care Cervical Cancer Diagnostic with 91% Sensitivity